# Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

> **NCT07223658** · PHASE1,PHASE2 · RECRUITING · sponsor: **Arrowhead Pharmaceuticals** · enrollment: 78 (estimated)

## Conditions studied

- Hyperlipidemia; Mixed

## Interventions

- **DRUG:** ARO-DIMERPA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07223658
- **Lead sponsor:** Arrowhead Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-22
- **Primary completion:** 2026-06
- **Final completion:** 2027-07
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07223658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07223658, "Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07223658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*